Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Pharmaceutical Packaging (Plastic Bottles, Parenteral Containers, Blister Packaging, Other Primary Packaging, Closures, Labels and Others) Market : Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2014 - 2020

  • ZIO1027688
  • 110 Pages
  • February 2016
  • Pharmaceuticals
Download Sample    Get Discount   
 


The report covers forecast and analysis for the pharmaceutical packaging market on a global and regional level. The study provides historic data of 2014 along with a forecast from 2015 to 2020 based on revenue (USD billion). The study includes drivers and restraints of the pharmaceutical packaging market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the pharmaceutical packaging market on a global level.

In order to give the users of this report a comprehensive view on the pharmaceutical packaging market, we have included a detailed competitive scenario and product portfolio of key vendors. To understand the competitive landscape in the market, an analysis of Porter’s five forces model for the pharmaceutical packaging market has also been included. The study encompasses a market attractiveness analysis, wherein product segments are benchmarked based on their market size, growth rate and general attractiveness.

The study provides a decisive view on the pharmaceutical packaging market by segmenting the market based on products and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2014 to 2020. Based on products, pharmaceutical packaging market can segmented into The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and Middle East and Africa with its further bifurcation into major countries including U.S., Germany, France, UK, China, Japan, India and Brazil.

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global pharmaceutical packaging market MeadWestvaco Corporation, Schott AG, Amcor Ltd., Rexam PLC, Gerresheimer AG , Becton Dickinson, NYPRO Inc., Vitro, S.A.B. De C.V., Datwyler Holding Inc and Aptargroup, Inc. The detailed description of players includes parameters such as company overview, financial overview, business strategies and recent developments of the company.

This report segments the global pharmaceutical packaging market as follows:


Global Pharmaceutical Packaging Market: Product Segment Analysis

  • Plastic Bottles
  • Parenteral Containers
  • Blister Packaging,
  • Other Primary Packaging
  • Closures
  • Labels
  • Others

Global Pharmaceutical Packaging Market: Regional Segment Analysis

  • North America

    • U.S.

  • Europe

    • Germany
    • France
    • UK

  • Asia Pacific

    • China
    • Japan
    • India

  • Latin America

    • Brazil

  • Middle East and Africa

  • Chapter 1. Introduction

    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology

      • 1.3.1. Market research process
      • 1.3.2. Market research methodology

  • Chapter 2. Executive Summary

    • 2.1. Global pharmaceutical packaging market revenue, 2014 - 2020 (USD Billion)
    • 2.2. Global pharmaceutical packaging market: Snapshot

  • Chapter 3. Pharmaceutical Packaging Market –Industry Analysis

    • 3.1. Pharmaceutical packaging: Market dynamics
    • 3.2. Market drivers

      • 3.2.1. Global pharmaceutical packaging market drivers: Impact analysis
      • 3.2.2. Advanced packaging types to enhance consumer consumption

    • 3.3. Market restraints

      • 3.3.1. Global pharmaceutical packaging market restraints: Impact analysis
      • 3.3.2. Price volatility of raw materials

    • 3.4. Opportunities

      • 3.4.1. Rising demand from Asia Pacific

    • 3.5. Porter’s five forces analysis

      • 3.5.1. Bargaining power of suppliers
      • 3.5.2. Bargaining power of buyers
      • 3.5.3. Threat from new entrants
      • 3.5.4. Threat from new substitutes
      • 3.5.5. Degree of competition

    • 3.6. Market attractiveness analysis

      • 3.6.1. Market attractiveness analysis by product segment
      • 3.6.2. Market attractiveness analysis by regional segment

  • Chapter 4. Global Pharmaceutical Packaging Market – Competitive Landscape

    • 4.1. Global pharmaceutical packaging: company market share
    • 4.2. Global pharmaceutical packaging market : Price trend Analysis

  • Chapter 5. Global Pharmaceutical Packaging Market – Product Segment Analysis

    • 5.1. Global pharmaceutical packaging market: Product overview

      • 5.1.1. Global pharmaceutical packaging market volume share by product, 2014 and 2020

    • 5.2. Plastic Bottles

      • 5.2.1. Global plastic bottles market, 2014 – 2020 (USD Billion)

    • 5.3. Parenteral Containers

      • 5.3.1. Global parenteral containers market, 2014 – 2020 (USD Billion)

    • 5.4. Blister Packaging

      • 5.4.1. Global blister packaging market, 2014 – 2020 (USD Billion)

    • 5.5. Other Primary Packaging

      • 5.5.1. Global other primary packaging market, 2014 – 2020 (USD Billion)

    • 5.6. Closures

      • 5.6.1. Global closures market, 2014 – 2020 (USD Billion)

    • 5.7. Labels

      • 5.7.1. Global labels market, 2014 – 2020 (USD Billion)

    • 5.8. Others

      • 5.8.1. Global other pharmaceutical packaging market, 2014 – 2020 (USD Billion)

  • Chapter 6. Global Pharmaceutical Packaging Market – Regional Segment Analysis

    • 6.1. Global pharmaceutical packaging market: Regional overview

      • 6.1.1. Global pharmaceutical packaging market volume share, by region, 2014 and 2020

    • 6.2. North America

      • 6.2.1. North America pharmaceutical packaging market revenue, by product, 2014 – 2020, (USD Billion)
      • 6.2.2. U.S.

        • 6.2.2.1. U.S. pharmaceutical packaging market revenue, by product, 2014 – 2020 (USD Billion)

    • 6.3. Europe

      • 6.3.1. Europe pharmaceutical packaging market revenue, by product, 2014 – 2020 (USD Billion)
      • 6.3.2. Germany

        • 6.3.2.1. Germany pharmaceutical packaging market revenue, by product, 2014 – 2020, (USD Billion)

      • 6.3.3. France

        • 6.3.3.1. France pharmaceutical packaging market revenue, by product, 2014 – 2020, (USD Billion)

      • 6.3.4. UK

        • 6.3.4.1. UK pharmaceutical packaging market revenue, by product, 2014 – 2020 (USD Billion)

    • 6.4. Asia Pacific

      • 6.4.1. Asia Pacific pharmaceutical packaging market revenue, by product, 2014 – 2020 (USD Billion)
      • 6.4.2. China

        • 6.4.2.1. China pharmaceutical packaging market revenue, by product, 2014 – 2020 (USD Billion)

      • 6.4.3. Japan

        • 6.4.3.1. Japan pharmaceutical packaging market revenue, by product, 2014 – 2020 (USD Billion)

      • 6.4.4. India

        • 6.4.4.1. India pharmaceutical packaging market revenue, by product, 2014 – 2020 (USD Billion)

    • 6.5. Latin America

      • 6.5.1. Latin America pharmaceutical packaging market revenue, by product, 2014 – 2020 (USD Billion)
      • 6.5.2. Brazil

        • 6.5.2.1. Brazil pharmaceutical packaging market revenue, by product, 2014 – 2020 (USD Billion)

    • 6.6. Middle East and Africa

      • 6.6.1. Middle East and Africa pharmaceutical packaging market revenue, by product, 2014 – 2020 (USD Billion)

  • Chapter 7. Company Profile

    • 7.1. Schott AG

      • 7.1.1. Overview
      • 7.1.2. Financials
      • 7.1.3. Product portfolio
      • 7.1.4. Business strategy
      • 7.1.5. Recent developments

    • 7.2. Amcor Ltd.

      • 7.2.1. Overview
      • 7.2.2. Financials
      • 7.2.3. Product portfolio
      • 7.2.4. Business strategy
      • 7.2.5. Recent developments

    • 7.3. Rexam PLC

      • 7.3.1. Overview
      • 7.3.2. Financials
      • 7.3.3. Product portfolio
      • 7.3.4. Business strategy
      • 7.3.5. Recent developments

    • 7.4. Gerresheimer AG

      • 7.4.1. Overview
      • 7.4.2. Financials
      • 7.4.3. Product portfolio
      • 7.4.4. Business strategy
      • 7.4.5. Recent developments

    • 7.5. NYPRO Inc.

      • 7.5.1. Overview
      • 7.5.2. Financials
      • 7.5.3. Product portfolio
      • 7.5.4. Business strategy
      • 7.5.5. Recent developments

    • 7.6. Vitro

      • 7.6.1. Overview
      • 7.6.2. Financials
      • 7.6.3. Product portfolio
      • 7.6.4. Business strategy
      • 7.6.5. Recent developments

    • 7.7. Datwyler Holding Inc

      • 7.7.1. Overview
      • 7.7.2. Financials
      • 7.7.3. Product portfolio
      • 7.7.4. Business strategy
      • 7.7.5. Recent developments

    • 7.8. Aptargroup, Inc

      • 7.8.1. Overview
      • 7.8.2. Financials
      • 7.8.3. Product portfolio
      • 7.8.4. Business strategy
      • 7.8.5. Recent developments

    • 7.9. MeadWestvaco Corporation

      • 7.9.1. Overview
      • 7.9.2. Financials
      • 7.9.3. Product portfolio
      • 7.9.4. Business strategy
      • 7.9.5. Recent developments

    • 7.10. Capsugel Inc.

      • 7.10.1. Overview
      • 7.10.2. Financials
      • 7.10.3. Product portfolio
      • 7.10.4. Business strategy
      • 7.10.5. Recent developments

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390